| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.54 | 0.07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |